Probenecid Inhibits Extracellular Signal-Regulated Kinase and C-Jun N-Terminal Kinase Mitogen-Activated Protein Kinase Pathways in Regulating Respiratory Syncytial Virus Response

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2024 Nov 27

PMID 39596517

Authors

Les P Jones

Harrison C Bergeron

David E Martin

Jackelyn Murray

Fred D Sancilio

Ralph A Tripp

Affiliations

Soon will be listed here.

Abstract

Background: We have previously shown that probenecid inhibits RSV, influenza virus, and SARS-CoV-2 replication in vitro in preclinical animal models and in humans. In a Phase two randomized, placebo-controlled, single-blind, dose range-finding study using probenecid to treat non-hospitalized patients with symptomatic, mild-to-moderate COVID-19, we previously showed that a 1000 mg twice daily treatment for 5 days reduced the median time to viral clearance from 11 to 7 days, and a 500 mg twice daily treatment for 5 days reduced the time to viral clearance from 11 to 9 days more than the placebo.

Methods: In this study, we sought to determine the mechanism of action of the probenecid inhibition of RSV replication in human respiratory epithelial (A549) cells.

Results: We show that probenecid inhibits the RSV-induced phosphorylation of JNKs and ERKs and the downstream phosphorylation of c-jun, a component of the AP-1 transcription complex needed for virus replication. The inhibition of JNKs by probenecid reversed the repression of transcription factor HNF-4.

Conclusion: The probenecid inhibition of JNK and ERK phosphorylation involves the MAPK pathway that precludes virus replication.

References

Caly L, Li H, Bogoyevitch M, Jans D . c-Jun N-terminal kinase activity is required for efficient respiratory syncytial virus production. Biochem Biophys Res Commun. 2017; 483(1):64-68. DOI: 10.1016/j.bbrc.2017.01.005. View

Chen J, Ye C, Wan C, Li G, Peng L, Peng Y . The Roles of c-Jun N-Terminal Kinase (JNK) in Infectious Diseases. Int J Mol Sci. 2021; 22(17). PMC: 8431791. DOI: 10.3390/ijms22179640. View

Strasfeld L, Chou S . Antiviral drug resistance: mechanisms and clinical implications. Infect Dis Clin North Am. 2010; 24(2):413-37. PMC: 2871161. DOI: 10.1016/j.idc.2010.01.001. View

Chang L, Yuan W, Zhu L . β-cantenin is potentially involved in the regulation of c-Jun signaling following bovine herpesvirus 1 infection. Vet Microbiol. 2020; 248:108804. PMC: 7414362. DOI: 10.1016/j.vetmic.2020.108804. View

Wei L, Zhu S, Ruan G, Hou L, Wang J, Wang B . Infectious bursal disease virus-induced activation of JNK signaling pathway is required for virus replication and correlates with virus-induced apoptosis. Virology. 2011; 420(2):156-63. DOI: 10.1016/j.virol.2011.08.027. View

Busca R, Pouyssegur J, Lenormand P . ERK1 and ERK2 Map Kinases: Specific Roles or Functional Redundancy?. Front Cell Dev Biol. 2016; 4:53. PMC: 4897767. DOI: 10.3389/fcell.2016.00053. View

Schreck I, Al-Rawi M, Mingot J, Scholl C, Diefenbacher M, ODonnell P . c-Jun localizes to the nucleus independent of its phosphorylation by and interaction with JNK and vice versa promotes nuclear accumulation of JNK. Biochem Biophys Res Commun. 2011; 407(4):735-40. DOI: 10.1016/j.bbrc.2011.03.092. View

Eron Jr J . HIV-1 protease inhibitors. Clin Infect Dis. 2000; 30 Suppl 2:S160-70. DOI: 10.1086/313853. View

Monick M, Cameron K, Staber J, Powers L, Yarovinsky T, Koland J . Activation of the epidermal growth factor receptor by respiratory syncytial virus results in increased inflammation and delayed apoptosis. J Biol Chem. 2004; 280(3):2147-58. DOI: 10.1074/jbc.M408745200. View

10.

Martovetsky G, Tee J, Nigam S . Hepatocyte nuclear factors 4α and 1α regulate kidney developmental expression of drug-metabolizing enzymes and drug transporters. Mol Pharmacol. 2013; 84(6):808-23. PMC: 3834141. DOI: 10.1124/mol.113.088229. View

11.

Tripp R, Martin D . Repurposing Probenecid to Inhibit SARS-CoV-2, Influenza Virus, and Respiratory Syncytial Virus (RSV) Replication. Viruses. 2022; 14(3). PMC: 8955960. DOI: 10.3390/v14030612. View

12.

Mathew C, Tamir S, Tripp R, Ghildyal R . Reversible disruption of XPO1-mediated nuclear export inhibits respiratory syncytial virus (RSV) replication. Sci Rep. 2021; 11(1):19223. PMC: 8479129. DOI: 10.1038/s41598-021-98767-2. View

13.

Kipper S, Hamad S, Caly L, Avrahami D, Bacharach E, Jans D . New host factors important for respiratory syncytial virus (RSV) replication revealed by a novel microfluidics screen for interactors of matrix (M) protein. Mol Cell Proteomics. 2015; 14(3):532-43. PMC: 4349975. DOI: 10.1074/mcp.M114.044107. View

14.

Kalinowski A, Galen B, Ueki I, Sun Y, Mulenos A, Osafo-Addo A . Respiratory syncytial virus activates epidermal growth factor receptor to suppress interferon regulatory factor 1-dependent interferon-lambda and antiviral defense in airway epithelium. Mucosal Immunol. 2018; 11(3):958-967. PMC: 6431552. DOI: 10.1038/mi.2017.120. View

15.

Murray J, Martin D, Sancilio F, Tripp R . Antiviral Activity of Probenecid and Oseltamivir on Influenza Virus Replication. Viruses. 2023; 15(12). PMC: 10748304. DOI: 10.3390/v15122366. View

16.

Shekhova E . Mitochondrial reactive oxygen species as major effectors of antimicrobial immunity. PLoS Pathog. 2020; 16(5):e1008470. PMC: 7255592. DOI: 10.1371/journal.ppat.1008470. View

17.

Yarza R, Vela S, Solas M, Ramirez M . c-Jun N-terminal Kinase (JNK) Signaling as a Therapeutic Target for Alzheimer's Disease. Front Pharmacol. 2016; 6:321. PMC: 4709475. DOI: 10.3389/fphar.2015.00321. View

18.

Dupuy L, Dobson S, Bitko V, Barik S . Casein kinase 2-mediated phosphorylation of respiratory syncytial virus phosphoprotein P is essential for the transcription elongation activity of the viral polymerase; phosphorylation by casein kinase 1 occurs mainly at Ser(215) and is without.... J Virol. 1999; 73(10):8384-92. PMC: 112856. DOI: 10.1128/JVI.73.10.8384-8392.1999. View

19.

Nigam S, Bush K, Martovetsky G, Ahn S, Liu H, Richard E . The organic anion transporter (OAT) family: a systems biology perspective. Physiol Rev. 2014; 95(1):83-123. PMC: 4281586. DOI: 10.1152/physrev.00025.2013. View

20.

Murray J, Hogan R, Martin D, Blahunka K, Sancilio F, Balyan R . Probenecid inhibits SARS-CoV-2 replication in vivo and in vitro. Sci Rep. 2021; 11(1):18085. PMC: 8433326. DOI: 10.1038/s41598-021-97658-w. View